NeurOp, Inc.

NeurOp, Inc. is a clinical-stage biotechnology company developing medicines for CNS disorders including severe pain, catastrophic childhood epilepsies and subarachnoid hemorrhage.

Latest News

NeurOp Initiates Phase 1 Clinical Trial of NMDA Receptor Inhibitor NP10679

read more...

Our Science

Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.

About Us

Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.